Ironwood Pharmaceuticals (IRWD)
Add to Watchlists Create an AlertIronwood Pharmaceuticals Income from Cont. Ops Quarterly
Ironwood Pharmaceuticals Income from Cont. Ops Quarterly Chart
View Income from Cont. Ops Quarterly for IRWD.
Start Your YCharts Pro Gold Membership.
Ironwood Pharmaceuticals Historical Income from Cont. Ops Quarterly Data
Pro Data ExportThere is no data for the selected date range.
About Income from Continuing Operations
Income Statement line item that does not account extraordinary items and discontinued operations. This metric is frequently used because it excludes items that are unlikely to happen the next reporting period.
For instance, if MSFT had five billion in Income, and 2 billion in an exceptional item charge, its income would be a reported 3 billion. Because the exceptional charge is unlikely to be repeated in the next quarter, some investors prefer to see what MSFT's income was BEFORE charges.
Learn More
View Income from Cont. Ops Quarterly for IRWD.
Start Your YCharts Pro Gold Membership.
Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle.
YCharts Pro is only $49/month, and comes with a 14-day free trial.
Get Started NowAlready a YCharts Pro Gold Member? Sign in here.
IRWD Income from Cont. Ops Quarterly Benchmarks
| Companies | |
|---|---|
| Forest Laboratories | Go Pro |
| Valeant Pharmaceuticals International | Go Pro |
| Synergy Pharmaceuticals | Go Pro |
IRWD Income from Cont. Ops Quarterly Rankings
| Overall |
35th percentile 5133 of 8006 |
| Sector |
14th percentile 588 of 686 in Healthcare |
| Industry |
10th percentile 58 of 65 in Diagnostics & Research |
IRWD Income from Cont. Ops Quarterly Range, Past 5 Years
| Minimum | Go Pro | Mar 2013 |
| Maximum | Go Pro | Sep 2012 |
| Average | Go Pro |